Cargando…

Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Microinvasive breast carcinoma is an infiltrating carcinoma that measures ≤1 mm. The prognostic factors associated with this disease have not been extensively investigated. In this study, we aimed to perform a systematic review and meta-analysis to examine the prognostic factors of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrosini-Spaltro, Andrea, Di Donato, Francesco, Saragoni, Luca, Cserni, Gábor, Rakha, Emad, Foschini, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252130/
https://www.ncbi.nlm.nih.gov/pubmed/37296968
http://dx.doi.org/10.3390/cancers15113007
_version_ 1785056097659256832
author Ambrosini-Spaltro, Andrea
Di Donato, Francesco
Saragoni, Luca
Cserni, Gábor
Rakha, Emad
Foschini, Maria Pia
author_facet Ambrosini-Spaltro, Andrea
Di Donato, Francesco
Saragoni, Luca
Cserni, Gábor
Rakha, Emad
Foschini, Maria Pia
author_sort Ambrosini-Spaltro, Andrea
collection PubMed
description SIMPLE SUMMARY: Microinvasive breast carcinoma is an infiltrating carcinoma that measures ≤1 mm. The prognostic factors associated with this disease have not been extensively investigated. In this study, we aimed to perform a systematic review and meta-analysis to examine the prognostic factors of microinvasive breast carcinoma. From 618 screened records, 5 were selected. The meta-analyses found a significant association between lymph node status and prognosis. No significant prognostic impacts were found for the following factors: estrogen receptor, progesterone receptor, HER2 status, multifocality or grade of microinvasion, or patient’s age. Therefore, the data obtained demonstrate that lymph node status is a main prognostic factor of microinvasive breast carcinoma. ABSTRACT: (1) Background: The prognostic factors of microinvasive (≤1 mm) breast carcinoma are not completely clear. The aim of this study was to perform a systematic review and meta-analysis to clarify these factors. (2) Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was followed. Two databases were interrogated, PubMed and Embase, and papers in English were included to address this question. The selected studies were those that reported on female patients affected by microinvasive carcinoma, and on prognostic factors with a hazard ratio (HR) for disease-free survival (DFS) and overall survival (OS). (3) Results: In total, 618 records were identified. After removing duplicates (166), identification, and screening (336 by title and abstract alone, 116 by full text and eventual supplementary material), 5 papers were selected. Seven different meta-analyses were conducted in this study, all referring to DFS, analyzing the following prognostic factors: estrogen receptor, progesterone receptor, HER2 status, multifocality and grade of microinvasion, patient’s age, and lymph node status. Only lymph node status was associated with prognosis and DFS (total number of cases: 1528; Z = 1.94; p = 0.05). The other factors examined did not significantly affect prognosis (p > 0.05). (4) Conclusions: Positive lymph node status significantly worsens prognosis in patients with microinvasive breast carcinoma.
format Online
Article
Text
id pubmed-10252130
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102521302023-06-10 Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis Ambrosini-Spaltro, Andrea Di Donato, Francesco Saragoni, Luca Cserni, Gábor Rakha, Emad Foschini, Maria Pia Cancers (Basel) Systematic Review SIMPLE SUMMARY: Microinvasive breast carcinoma is an infiltrating carcinoma that measures ≤1 mm. The prognostic factors associated with this disease have not been extensively investigated. In this study, we aimed to perform a systematic review and meta-analysis to examine the prognostic factors of microinvasive breast carcinoma. From 618 screened records, 5 were selected. The meta-analyses found a significant association between lymph node status and prognosis. No significant prognostic impacts were found for the following factors: estrogen receptor, progesterone receptor, HER2 status, multifocality or grade of microinvasion, or patient’s age. Therefore, the data obtained demonstrate that lymph node status is a main prognostic factor of microinvasive breast carcinoma. ABSTRACT: (1) Background: The prognostic factors of microinvasive (≤1 mm) breast carcinoma are not completely clear. The aim of this study was to perform a systematic review and meta-analysis to clarify these factors. (2) Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology was followed. Two databases were interrogated, PubMed and Embase, and papers in English were included to address this question. The selected studies were those that reported on female patients affected by microinvasive carcinoma, and on prognostic factors with a hazard ratio (HR) for disease-free survival (DFS) and overall survival (OS). (3) Results: In total, 618 records were identified. After removing duplicates (166), identification, and screening (336 by title and abstract alone, 116 by full text and eventual supplementary material), 5 papers were selected. Seven different meta-analyses were conducted in this study, all referring to DFS, analyzing the following prognostic factors: estrogen receptor, progesterone receptor, HER2 status, multifocality and grade of microinvasion, patient’s age, and lymph node status. Only lymph node status was associated with prognosis and DFS (total number of cases: 1528; Z = 1.94; p = 0.05). The other factors examined did not significantly affect prognosis (p > 0.05). (4) Conclusions: Positive lymph node status significantly worsens prognosis in patients with microinvasive breast carcinoma. MDPI 2023-05-31 /pmc/articles/PMC10252130/ /pubmed/37296968 http://dx.doi.org/10.3390/cancers15113007 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Ambrosini-Spaltro, Andrea
Di Donato, Francesco
Saragoni, Luca
Cserni, Gábor
Rakha, Emad
Foschini, Maria Pia
Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
title Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
title_full Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
title_fullStr Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
title_full_unstemmed Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
title_short Prognostic Markers of Microinvasive Breast Carcinoma: A Systematic Review and Meta-Analysis
title_sort prognostic markers of microinvasive breast carcinoma: a systematic review and meta-analysis
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252130/
https://www.ncbi.nlm.nih.gov/pubmed/37296968
http://dx.doi.org/10.3390/cancers15113007
work_keys_str_mv AT ambrosinispaltroandrea prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis
AT didonatofrancesco prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis
AT saragoniluca prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis
AT csernigabor prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis
AT rakhaemad prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis
AT foschinimariapia prognosticmarkersofmicroinvasivebreastcarcinomaasystematicreviewandmetaanalysis